The giant pharmaceutical conglomerate Johnson & Johnson (J&J) has faced some serious allegations this year with respect to its most promising star product Invokana. The company had sales of $71.9 billion for the full-year 2016, an increase of 2.6% compared with its 2015 sales. Sales soared due to millions spent by the company in promoting … [Read more...]
Consolidation of Invokana Claims
Diabetes has become an epidemic. According to Diabetes.org, 9.3% (29.1 million) of the American population was reported to have diabetes in 2012. 8.9 million of these cases were undiagnosed. While diabetes is manageable in many cases, it can sometimes result in death. It is currently ranked 7th amongst the top leading causes of death in the US. … [Read more...]
FDA Strengthens Warning of Kidney Damage on Diabetes Drugs
Newer Type 2 diabetes drugs, called sodium-glucose co-transporter 2 (SGLT2) inhibitors, hit the market in March, 2013. Invokana (canagliflozin) was the first to receive approval from the U.S. Food and Drug Administration (FDA). Since then SGLT2 inhibitors have been linked to serious side effects, including kidney damage. Now, based on recent … [Read more...]
Invokana Lawsuit Frequently Asked Questions
By Desiree Housek, Staff Writer If you or a loved one has taken Invokana and experienced kidney failure other other serious side effects, you may be entitled to compensation. Here are some of the most common questions asked about Invokana, its side effects and the current Invokana litigation. What is Invokana? Invokana is part of a class … [Read more...]
Invokana – Questions & Answers
Among the leading causes of death in the United States, diabetes ranks 7th. Type 2 diabetes is the most common form, occurring when the body does not use insulin properly. Left untreated, type 2 diabetes can lead to nerve damage, blindness, heart disease, stroke, kidney failure and other health issues. Numerous prescription medications can help … [Read more...]
Recent Comments